Molluscum contagiosum infection associated with pimecrolimus use in pityriasis alba

Pediatric Dermatology

Volumn 24, Issue 5, 2007, Pages

  Goksugur, Nadir ^a,c   Ozbostanci, Betul ^a   Goksugur, Sevil Bilir ^b  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^c Izzet Baysal Medical Faculty   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PIMECROLIMUS;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; ERYTHEMA STREPTOGENES; HUMAN; MALE; MOLLUSCUM CONTAGIOSUM; PAPULE; PITYRIASIS; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; ADOLESCENT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MOLLUSCUM CONTAGIOSUM; MOLLUSCUM CONTAGIOSUM VIRUS; PITYRIASIS; TACROLIMUS;

EID: 35448951613     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2007.00443.x     Document Type: Article

References (15)

1. Darsow U, Lubbe J, Taieb A et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005 19 : 286 295.
2. Hultsch T, Kapp A, Spergel J. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 2005 211 : 174 187.
3. Gisondi P, Ellis CN, Girolomoni G. Pimecrolimus in dermatology: atopic dermatitis and beyond. Int J Clin Pract 2005 59 : 969 974.
4. Hanifin JM, Paller AS, Eichenfield L et al. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol 2005 53 : 186 194.
5. Lubbe J, Pournaras C, Saurat JH. Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment. Dermatology 2000 201 : 249 251.
6. Ahn BK, Kim BD, Lee SJ et al. Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment. J Am Acad Dermatol 2005 52 : 532 533.
7. Wilson LM, Reid CM. Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment. Australas J Dermatol 2004 45 : 184 185.
8. Lerbaek A, Agner T. Facial eruption of molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus. Br J Dermatol 2004 150 : 1210 1211.
9. Wetzel S, Wollenberg A. Eczema molluscatum in tacrolimus treated atopic dermatitis. Eur J Dermatol 2004 14 : 73 74.
10. Billich A, Aschauer H, Aszodi A et al. Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm 2004 269 : 29 35.
11. Paller AS, Lebwohl M, Fleischer AB Jr. et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol 2005 52 : 810 822.
12. Meingassner JG, Grassberger M, Fahrngruber H et al. A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology. Br J Dermatol 1997 137 : 568 576.
13. Wahn U, Bos JD, Goodfield M et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 2002 110 : 1 8.
14. Ashcroft DM, Dimmock P, Garside R et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005 330 : 516.
15. Lubbe J. Secondary infections in patients with atopic dermatitis. Am J Clin Dermatol 2003 4 : 641 654.